Federal Register Notice: FDA has submitted a proposed collection of information entitled, “National Direct-to-Consumer Advertising Survey,” to the Office of Management and Budget for review and clearance under the Paperwork Reduction Act of 1995. The purpose of the survey is to collect updated insights on consumer experiences with and attitudes towards DTC promotion of prescription drugs. FDA last surveyed patients about their experiences with DTC advertising in 2002 and numerous changes have occurred including declines in print readership, the rise in online prescription drug promotion, and self-imposed industry guidelines for DTC advertising. To view this notice, click here.